FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801681704> ?p ?o ?g. }

• W2801681704 endingPage "10" @default.
• W2801681704 startingPage "1" @default.
• W2801681704 abstract "Heart failure continues to be a major global health problem with a pronounced impact on morbidity and mortality and very limited drug treatment options especially with regard to inotropic therapy. Omecamtiv mecarbil is a first-in-class cardiac myosin activator, which increases the proportion of myosin heads that are tightly bound to actin and creates a force-producing state that is not associated with cytosolic calcium accumulation. Phase I and phase II studies have shown that it is safe and well tolerated. It produces dose-dependent increases in systolic ejection time (SET), stroke volume (SV), left ventricular ejection fraction (LVEF), and fractional shortening. In the ATOMIC-AHF trial, intravenous (IV) omecamtiv mecarbil did not improve dyspnoea overall but may have improved it in a high-dose group of acute heart failure patients. It did, however, increase SET, decrease left ventricular end-systolic diameter, and was well tolerated. The COSMIC-HF trial showed that a pharmacokinetic-based dose-titration strategy of oral omecamtiv mecarbil improved cardiac function and reduced ventricular diameters compared to placebo and had a similar safety profile. It also significantly reduced plasma N-terminal-pro B-type natriuretic peptide compared with placebo. The GALACTIC-HF trial is now underway and will compare omecamtiv mecarbil with placebo when added to current heart failure standard treatment in patients with chronic heart failure and reduced LVEF. It is expected to be completed in January 2021. The ongoing range of preclinical and clinical research on omecamtiv mecarbil will further elucidate its full range of pharmacological effects and its clinical usefulness in heart failure." @default.
• W2801681704 created "2018-05-17" @default.
• W2801681704 creator A5029342822 @default.
• W2801681704 creator A5081929932 @default.
• W2801681704 date "2018-04-23" @default.
• W2801681704 modified "2023-09-26" @default.
• W2801681704 title "Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil" @default.
• W2801681704 cites W1504229945 @default.
• W2801681704 cites W1984193593 @default.
• W2801681704 cites W1984848816 @default.
• W2801681704 cites W1985928412 @default.
• W2801681704 cites W1987036055 @default.
• W2801681704 cites W2002867874 @default.
• W2801681704 cites W2030248934 @default.
• W2801681704 cites W2049658384 @default.
• W2801681704 cites W2061143322 @default.
• W2801681704 cites W2068810785 @default.
• W2801681704 cites W2077146886 @default.
• W2801681704 cites W2089369921 @default.
• W2801681704 cites W2090002414 @default.
• W2801681704 cites W2091296046 @default.
• W2801681704 cites W2109322986 @default.
• W2801681704 cites W2113698123 @default.
• W2801681704 cites W2126617656 @default.
• W2801681704 cites W2134898232 @default.
• W2801681704 cites W2135958771 @default.
• W2801681704 cites W2136728517 @default.
• W2801681704 cites W2143077915 @default.
• W2801681704 cites W2149146343 @default.
• W2801681704 cites W2187004430 @default.
• W2801681704 cites W2309452508 @default.
• W2801681704 cites W2427094903 @default.
• W2801681704 cites W2532713595 @default.
• W2801681704 cites W2558812366 @default.
• W2801681704 cites W2595612803 @default.
• W2801681704 cites W2606853863 @default.
• W2801681704 cites W2608624392 @default.
• W2801681704 cites W2779042825 @default.
• W2801681704 cites W2916269539 @default.
• W2801681704 cites W59066530 @default.
• W2801681704 doi "https://doi.org/10.7573/dic.212518" @default.
• W2801681704 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5916097" @default.
• W2801681704 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29707029" @default.
• W2801681704 hasPublicationYear "2018" @default.
• W2801681704 type Work @default.
• W2801681704 sameAs 2801681704 @default.
• W2801681704 citedByCount "36" @default.
• W2801681704 countsByYear W28016817042019 @default.
• W2801681704 countsByYear W28016817042020 @default.
• W2801681704 countsByYear W28016817042021 @default.
• W2801681704 countsByYear W28016817042022 @default.
• W2801681704 countsByYear W28016817042023 @default.
• W2801681704 crossrefType "journal-article" @default.
• W2801681704 hasAuthorship W2801681704A5029342822 @default.
• W2801681704 hasAuthorship W2801681704A5081929932 @default.
• W2801681704 hasBestOaLocation W28016817041 @default.
• W2801681704 hasConcept C126322002 @default.
• W2801681704 hasConcept C142724271 @default.
• W2801681704 hasConcept C155710745 @default.
• W2801681704 hasConcept C164705383 @default.
• W2801681704 hasConcept C204787440 @default.
• W2801681704 hasConcept C27081682 @default.
• W2801681704 hasConcept C2777099384 @default.
• W2801681704 hasConcept C2778198053 @default.
• W2801681704 hasConcept C71924100 @default.
• W2801681704 hasConcept C78085059 @default.
• W2801681704 hasConcept C80461066 @default.
• W2801681704 hasConcept C98274493 @default.
• W2801681704 hasConceptScore W2801681704C126322002 @default.
• W2801681704 hasConceptScore W2801681704C142724271 @default.
• W2801681704 hasConceptScore W2801681704C155710745 @default.
• W2801681704 hasConceptScore W2801681704C164705383 @default.
• W2801681704 hasConceptScore W2801681704C204787440 @default.
• W2801681704 hasConceptScore W2801681704C27081682 @default.
• W2801681704 hasConceptScore W2801681704C2777099384 @default.
• W2801681704 hasConceptScore W2801681704C2778198053 @default.
• W2801681704 hasConceptScore W2801681704C71924100 @default.
• W2801681704 hasConceptScore W2801681704C78085059 @default.
• W2801681704 hasConceptScore W2801681704C80461066 @default.
• W2801681704 hasConceptScore W2801681704C98274493 @default.
• W2801681704 hasLocation W28016817041 @default.
• W2801681704 hasLocation W28016817042 @default.
• W2801681704 hasLocation W28016817043 @default.
• W2801681704 hasLocation W28016817044 @default.
• W2801681704 hasLocation W28016817045 @default.
• W2801681704 hasOpenAccess W2801681704 @default.
• W2801681704 hasPrimaryLocation W28016817041 @default.
• W2801681704 hasRelatedWork W2051712573 @default.
• W2801681704 hasRelatedWork W2061321770 @default.
• W2801681704 hasRelatedWork W2077083067 @default.
• W2801681704 hasRelatedWork W2316342240 @default.
• W2801681704 hasRelatedWork W2334396920 @default.
• W2801681704 hasRelatedWork W2789205885 @default.
• W2801681704 hasRelatedWork W2965474825 @default.
• W2801681704 hasRelatedWork W3033076790 @default.
• W2801681704 hasRelatedWork W4200030969 @default.
• W2801681704 hasRelatedWork W4249414561 @default.
• W2801681704 hasVolume "7" @default.

• next